Works matching IS 11727047 AND DT 2020 AND VI 34 AND IP 2

Results: 8
    1
    2

    Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study.

    Published in:
    2020
    By:
    • Naismith, Robert T.;
    • Wundes, Annette;
    • Ziemssen, Tjalf;
    • Jasinska, Elzbieta;
    • Freedman, Mark S.;
    • Lembo, Anthony J.;
    • Selmaj, Krzysztof;
    • Bidollari, Ilda;
    • Chen, Hailu;
    • Hanna, Jerome;
    • Leigh-Pemberton, Richard;
    • Lopez-Bresnahan, Maria;
    • Lyons, Jennifer;
    • Miller, Catherine;
    • Rezendes, David;
    • Wolinsky, Jerry S.;
    • EVOLVE-MS-2 Study Group
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8